ITGA6 and cancer: It has been shown that Oct3/4-expressing cancer stem-like cells (express GFP under Oct3/4 promoter), isolated from breast cancer cell lines, and CD49f+ primary cancer cells exhibit higher topo I activity and protein level, and display increased sensitivity to topo I inhibitors [37].